<DOC>
	<DOCNO>NCT01644877</DOCNO>
	<brief_summary>This protocol seek enroll immunocompromised patient supplemental oxygen diagnose parainfluenza infection .</brief_summary>
	<brief_title>A Phase II , Randomized , Double-blind , Placebo-controlled Study Examine Effects DAS181 Immunocompromised Subjects With Lower Respiratory Tract Parainfluenza Infection Supplemental Oxygen</brief_title>
	<detailed_description />
	<mesh_term>Paramyxoviridae Infections</mesh_term>
	<criteria>Age ≥12 year Able provide inform consent , child assent parental consent surrogate consent applicable Currently invasive mechanical ventilation noninvasive positive pressure ventilation ( CPAP bilevel positive airway pressure ) require &gt; 2LPM supplemental oxygen therapy maintain O2 saturation &gt; 90 % due hypoxemia Immunocompromised , define one following : Autologous Allogeneic hematopoietic cell transplantation ( HSCT ) ; Lung lungheart transplantation ; Subjects treat chemotherapy hematologic malignancy ; Subjects treat chemotherapy solid tumor malignancy Confirmed parainfluenza screen one follow method use sample type : Respiratory Virus Panel , Direct fluorescent antibody ( DFA ) , Qualitative/quantitative RTPCR test parainfluenza virus perform local laboratory ( confirmatory PCR test do central lab require start patient study ) . Confirmed PIV low tract disease subject mechanical ventilation define PIV detection bronchoalveolar lavage ( BAL ) biopsy within last 7 day screen Confirmed PIV low tract disease subject noninvasive positive pressure ventilation supplemental oxygen define follow within last 7 day screen : New pulmonary infiltrate chest image least one PIV sign and/or symptom define section 10.3.6 Female subject childbearing potential capable conception must postmenopausal ( one year great without menses ) , surgically incapable childbearing , practice two effective method birth control . Acceptable method include abstinence , intrauterine device , spermicide , barrier , male partner surgical sterilization hormonal contraception . A female subject ≥18 year age child bear potential must agree practice two acceptable method birth control study period . All reproductive female subject must negative serum pregnancy test screen visit . Male subject must agree use medically accept form contraception study period . Abstinence acceptable method contraception . Psychiatric cognitive illness recreational drug/alcohol use , opinion principal investigator , would affect patient safety and/or compliance . Any significant finding patient 's medical history physical examination , opinion investigator , would affect patient safety compliance dose schedule . In opinion Investigator , subject low chance survival first 5 day treatment . Subjects treat oral , aerosolize intravenous ( IV ) ribavirin treatment PIV . A fortyeight hour ( 48 hr ) wash period prior randomization allow . Subjects history RSV MPV Subjects take investigational drug use research treat PIV . Subjects history allergic reaction lactose . Subjects history document Pseudomonas aeruginosa pneumonia confirm radiographically culture BAL .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>